Tirzepatide Recalled Over Safety and Sterility Concerns

Apothecary Pharma has pulled 22 vials of compounded tirzepatide from circulation nationwide after failing to guarantee the products were sterile. The North Carolina-based pharmaceutical company issued the voluntary recall for prescription tirzepatide injections supplied in 4 mL multidose vials at…